BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 24771510)

  • 61. Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor.
    North BJ; Almeciga-Pinto I; Tamang D; Yang M; Jones SS; Quayle SN
    PLoS One; 2017; 12(3):e0173507. PubMed ID: 28264055
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Synergistic effects of proteasome inhibitor and histone deacetylase inhibitor on apoptosis and aggresome formation in T lymphoma cells].
    Jiang XX; Zhang QL; Chen XY; Wu WL; Shen ZX; Zhao WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1215-9. PubMed ID: 19840453
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The HDAC6 inhibitor C1A modulates autophagy substrates in diverse cancer cells and induces cell death.
    Kaliszczak M; van Hechanova E; Li Y; Alsadah H; Parzych K; Auner HW; Aboagye EO
    Br J Cancer; 2018 Nov; 119(10):1278-1287. PubMed ID: 30318510
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combined treatment with bortezomib plus bafilomycin A1 enhances the cytocidal effect and induces endoplasmic reticulum stress in U266 myeloma cells: crosstalk among proteasome, autophagy-lysosome and ER stress.
    Kawaguchi T; Miyazawa K; Moriya S; Ohtomo T; Che XF; Naito M; Itoh M; Tomoda A
    Int J Oncol; 2011 Mar; 38(3):643-54. PubMed ID: 21174067
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells.
    Baradari V; Höpfner M; Huether A; Schuppan D; Scherübl H
    World J Gastroenterol; 2007 Sep; 13(33):4458-66. PubMed ID: 17724801
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Detrimental effects of proteasome inhibition activity in Drosophila melanogaster: implication of ER stress, autophagy, and apoptosis.
    Velentzas PD; Velentzas AD; Mpakou VE; Antonelou MH; Margaritis LH; Papassideri IS; Stravopodis DJ
    Cell Biol Toxicol; 2013 Feb; 29(1):13-37. PubMed ID: 23161111
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer.
    Xiao K; Li YP; Wang C; Ahmad S; Vu M; Kuma K; Cheng YQ; Lam KS
    Biomaterials; 2015 Oct; 67():183-93. PubMed ID: 26218744
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
    Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer.
    Bi J; Zhang Y; Malmrose PK; Losh HA; Newtson AM; Devor EJ; Thiel KW; Leslie KK
    Cell Death Dis; 2022 Jan; 13(1):59. PubMed ID: 35039480
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells.
    Yu C; Friday BB; Yang L; Atadja P; Wigle D; Sarkaria J; Adjei AA
    Neuro Oncol; 2008 Jun; 10(3):309-19. PubMed ID: 18445700
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro and in vivo interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib in non-Hodgkin lymphoma cells.
    Dasmahapatra G; Patel H; Friedberg J; Quayle SN; Jones SS; Grant S
    Mol Cancer Ther; 2014 Dec; 13(12):2886-97. PubMed ID: 25239935
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update.
    Sultana F; Manasa KL; Shaik SP; Bonam SR; Kamal A
    Curr Med Chem; 2019; 26(40):7212-7280. PubMed ID: 29852860
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Brazilin induces apoptosis and G2/M arrest via inactivation of histone deacetylase in multiple myeloma U266 cells.
    Kim B; Kim SH; Jeong SJ; Sohn EJ; Jung JH; Lee MH; Kim SH
    J Agric Food Chem; 2012 Oct; 60(39):9882-9. PubMed ID: 22967175
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma.
    Paoluzzi L; Scotto L; Marchi E; Zain J; Seshan VE; O'Connor OA
    Clin Cancer Res; 2010 Jan; 16(2):554-65. PubMed ID: 20068080
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synergistic effect of histone deacetylase inhibitors FK228 and m-carboxycinnamic acid bis-hydroxamide with proteasome inhibitors PSI and PS-341 against gastrointestinal adenocarcinoma cells.
    Adachi M; Zhang Y; Zhao X; Minami T; Kawamura R; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Jun; 10(11):3853-62. PubMed ID: 15173094
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells.
    Miller CP; Rudra S; Keating MJ; Wierda WG; Palladino M; Chandra J
    Blood; 2009 Apr; 113(18):4289-99. PubMed ID: 19182209
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The structural requirements of histone deacetylase inhibitors: SAHA analogs modified at the C5 position display dual HDAC6/8 selectivity.
    Negmeldin AT; Pflum MKH
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3254-3258. PubMed ID: 28648461
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Carfilzomib combined with suberanilohydroxamic acid (SAHA) synergistically promotes endoplasmic reticulum stress in non-small cell lung cancer cell lines.
    Hanke NT; Garland LL; Baker AF
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):549-60. PubMed ID: 26385374
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
    Boozari B; Mundt B; Woller N; Strüver N; Gürlevik E; Schache P; Kloos A; Knocke S; Manns MP; Wirth TC; Kubicka S; Kühnel F
    Gut; 2010 Oct; 59(10):1416-26. PubMed ID: 20675696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.